CANCER DRUGS
TODAY'S HEADLINES
The global oncology market was worth $107 billion in 2015, and global annual cancer drug costs surged by 11.5% from 2011 to 2015, according to a new report. Here are the other top 5 facts about US and global cancer drug costs. Read more |
|
FDA recently approved daclizumab (Zinbryta), a once-monthly, self-administered treatment for relapsing forms of multiple sclerosis. Why it's unique
|
CONTINUING PHARMACY EDUCATION
This month's CE activity, "Keep your patient moving: An overview of treatment options for constipation," is open for pharmacists and pharmacy technicians.
The goal of this program is to assist pharmacists and pharmacy technicians in their understanding of the role of linaclotide, lubiprostone, methylnaltrexone, and naloxegol in the treatment of constipation after conventional nonpharmacologic interventions and conventional laxatives such as bulking agents, osmotic laxatives, and stimulant laxatives have failed.
Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More
|
EDITOR'S PICK
In a major new entry into the competitive diabetes market, FDA just approved linagliptin and metformin hydrochloride extended-release tablets (Jentadueto XR) to treat type 2 diabetes. Read more
|
|
|
